Valeant Pharmaceuticals Completes Acquisition of Aton Pharma, Inc.

May 27, 2010

ALISO VIEJO, Calif., May 27, 2010 /PRNewswire via COMTEX/ --Valeant Pharmaceuticals International (NYSE: VRX) today announced that effective May 26, 2010, the company completed its acquisition of Aton Pharma, Inc., a specialty pharmaceutical company focused on ophthalmology and certain orphan drug indications, located in Lawrenceville, New Jersey.

About Valeant

Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at http://www.valeant.com/.


Contact:
Laurie W. Little
Valeant Pharmaceuticals
949-461-6002
laurie.little@valeant.com

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All